Germany’s IQWiG Downs Two Drugs In One Day
This article was originally published in The Pink Sheet Daily
Executive Summary
IQWiG turned down both GSK/Valeant’s Trobalt and Novartis’ Rasilamlo for lack of evidence of added benefit, after manufacturers’ choice of comparator deviated from those selected by the G-BA.